Monopar Therapeutics Inc. (MNPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Add to watchlist

5.08

-0.26

(-4.87%)

At close: 04:00PM EDT

4.95

-0.13

(-2.56%)

After hours:

04:27PM EDT

Major holders

Insider roster

Insider transactions

Currency in USD

Insider purchases - Last 6 months	Shares	Trans
Purchases	1,524,604	118
Sales	125,000	1
Net shares purchased (sold)	1,399,604	119
Total insider shares held	1.88M	N/A
% net shares purchased (sold)	293.00%	N/A

Net institutional purchases - Prior quarter to latest quarter	Shares
Net shares purchased (sold)	N/A
% change in institutional shares held	N/A

Insider transactions reported - last two years

Insider	Transaction	Type	Value	Date	Shares
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		28 June 2024	9,957
ROBINSON CHANDLER D Chief Executive Officer		Direct		28 June 2024	24,476
CITTADINE ANDREW Chief Operating Officer		Direct		28 June 2024	8,952
CITTADINE ANDREW Chief Operating Officer	Purchase at price 0.74 - 0.86 per share.	Direct	25,574	20 June 2024	32,508
CITTADINE ANDREW Chief Operating Officer	Purchase at price 0.90 - 0.93 per share.	Direct	32,894	17 June 2024	36,000
CITTADINE ANDREW Chief Operating Officer	Purchase at price 0.76 - 0.78 per share.	Direct	18,480	04 June 2024	24,000
CITTADINE ANDREW Chief Operating Officer	Purchase at price 0.64 per share.	Direct	23,051	31 May 2024	36,000
ROBINSON CHANDLER D Chief Executive Officer	Conversion of Exercise of derivative security at price 0.00 per share.	Direct	84	28 May 2024	84,000
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		28 Mar 2024	9,956
ROBINSON CHANDLER D Chief Executive Officer		Direct		28 Mar 2024	24,474
CITTADINE ANDREW Chief Operating Officer		Direct		28 Mar 2024	8,952
STARR CHRISTOPHER M Director		Direct		29 Dec 2023	2,533
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		29 Dec 2023	11,188
ANDERSON RAYMOND WILLIAM Director		Direct		29 Dec 2023	2,533
KLAUSNER ARTHUR J Director		Direct		29 Dec 2023	2,533
BROWN MICHAEL J Director		Direct		29 Dec 2023	2,533
ROBINSON CHANDLER D Chief Executive Officer		Direct		29 Dec 2023	31,198
CITTADINE ANDREW Chief Operating Officer		Direct		29 Dec 2023	8,952
STARR CHRISTOPHER M Director		Direct		29 Sept 2023	2,533
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		29 Sept 2023	9,956
ANDERSON RAYMOND WILLIAM Director		Direct		29 Sept 2023	2,533
KLAUSNER ARTHUR J Director		Direct		29 Sept 2023	2,533
BROWN MICHAEL J Director		Direct		29 Sept 2023	2,533
ROBINSON CHANDLER D Chief Executive Officer		Direct		29 Sept 2023	24,474
CITTADINE ANDREW Chief Operating Officer		Direct		29 Sept 2023	8,953
STARR CHRISTOPHER M Director		Direct		30 June 2023	2,534
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		30 June 2023	14,846
ANDERSON RAYMOND WILLIAM Director		Direct		30 June 2023	2,534
KLAUSNER ARTHUR J Director		Direct		30 June 2023	2,534
BROWN MICHAEL J Director		Direct		30 June 2023	2,534
ROBINSON CHANDLER D Chief Executive Officer		Direct		30 June 2023	35,039
CITTADINE ANDREW Chief Operating Officer		Direct		30 June 2023	13,841
STARR CHRISTOPHER M Director		Direct		31 Mar 2023	2,533
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		31 Mar 2023	5,067
ANDERSON RAYMOND WILLIAM Director		Direct		31 Mar 2023	2,533
KLAUSNER ARTHUR J Director		Direct		31 Mar 2023	2,533
BROWN MICHAEL J Director		Direct		31 Mar 2023	2,533
ROBINSON CHANDLER D Chief Executive Officer		Direct		31 Mar 2023	13,911
CITTADINE ANDREW Chief Operating Officer		Direct		31 Mar 2023	4,063
STARR CHRISTOPHER M Director		Direct		30 Dec 2022	2,859
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		30 Dec 2022	6,297
ANDERSON RAYMOND WILLIAM Director		Direct		30 Dec 2022	2,859
KLAUSNER ARTHUR J Director		Direct		30 Dec 2022	2,859
BROWN MICHAEL J Director		Direct		30 Dec 2022	2,859
ROBINSON CHANDLER D Chief Executive Officer		Direct		30 Dec 2022	20,635
CITTADINE ANDREW Chief Operating Officer		Direct		30 Dec 2022	4,062
CITTADINE ANDREW Chief Operating Officer	Purchase at price 3.00 - 3.15 per share.	Direct	49,659	15 Nov 2022	16,053
STARR CHRISTOPHER M Director		Direct		30 Sept 2022	2,859
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		30 Sept 2022	5,066
ANDERSON RAYMOND WILLIAM Director		Direct		30 Sept 2022	2,859
KLAUSNER ARTHUR J Director		Direct		30 Sept 2022	2,859
BROWN MICHAEL J Director		Direct		30 Sept 2022	2,859
ROBINSON CHANDLER D Chief Executive Officer		Direct		30 Sept 2022	13,911
CITTADINE ANDREW Chief Operating Officer		Direct		30 Sept 2022	4,063
STARR CHRISTOPHER M Director		Direct		30 June 2022	2,859
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		30 June 2022	8,913
ANDERSON RAYMOND WILLIAM Director		Direct		30 June 2022	2,859
KLAUSNER ARTHUR J Director		Direct		30 June 2022	2,859
BROWN MICHAEL J Director		Direct		30 June 2022	2,859
ROBINSON CHANDLER D Chief Executive Officer		Direct		30 June 2022	23,882
CITTADINE ANDREW Chief Operating Officer		Direct		30 June 2022	8,125
STARR CHRISTOPHER M Director		Direct		31 Mar 2022	2,859
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		31 Mar 2022	1,221
ANDERSON RAYMOND WILLIAM Director		Direct		31 Mar 2022	2,859
KLAUSNER ARTHUR J Director		Direct		31 Mar 2022	2,859
BROWN MICHAEL J Director		Direct		31 Mar 2022	2,859
ROBINSON CHANDLER D Chief Executive Officer		Direct		31 Mar 2022	3,941
MAZAR ANDREW PAUL Officer and Director		Direct		31 Mar 2022	1,606
STARR CHRISTOPHER M Director		Direct		31 Dec 2021	751
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		31 Dec 2021	1,221
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		31 Dec 2021	1,231
ANDERSON RAYMOND WILLIAM Director		Direct		31 Dec 2021	751
KLAUSNER ARTHUR J Director		Direct		31 Dec 2021	751
BROWN MICHAEL J Director		Direct		31 Dec 2021	751
ROBINSON CHANDLER D Chief Executive Officer		Direct		31 Dec 2021	3,941
ROBINSON CHANDLER D Chief Executive Officer		Direct		31 Dec 2021	6,724
MAZAR ANDREW PAUL Officer and Director		Direct		31 Dec 2021	1,606
MAZAR ANDREW PAUL Officer and Director		Direct		31 Dec 2021	1,937
STARR CHRISTOPHER M Director		Direct		30 Sept 2021	751
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		30 Sept 2021	1,221
ANDERSON RAYMOND WILLIAM Director		Direct		30 Sept 2021	751
KLAUSNER ARTHUR J Director		Direct		30 Sept 2021	751
BROWN MICHAEL J Director		Direct		30 Sept 2021	751
ROBINSON CHANDLER D Chief Executive Officer		Direct		30 Sept 2021	3,941
MAZAR ANDREW PAUL Officer and Director		Direct		30 Sept 2021	1,606
STARR CHRISTOPHER M Director		Direct		30 June 2021	752
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		30 June 2021	2,442
ANDERSON RAYMOND WILLIAM Director		Direct		30 June 2021	752
KLAUSNER ARTHUR J Director		Direct		30 June 2021	752
BROWN MICHAEL J Director		Direct		30 June 2021	752
ROBINSON CHANDLER D Chief Executive Officer		Direct		30 June 2021	7,883
MAZAR ANDREW PAUL Officer and Director		Direct		30 June 2021	3,212
STARR CHRISTOPHER M Director		Direct		31 Mar 2021	751
ANDERSON RAYMOND WILLIAM Director		Direct		31 Mar 2021	751
KLAUSNER ARTHUR J Director		Direct		31 Mar 2021	751
BROWN MICHAEL J Director		Direct		31 Mar 2021	751
TACTIC PHARMA, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Sale at price 10.60 per share.	Indirect	1,325,000	11 Feb 2021	125,000
TSUCHIMOTO-EVANS KIM R Chief Financial Officer		Direct		01 Jan 2021	1,231
ROBINSON CHANDLER D Chief Executive Officer		Direct		01 Jan 2021	6,724
MAZAR ANDREW PAUL Officer and Director		Direct		01 Jan 2021	1,937
STARR CHRISTOPHER M Director		Direct		31 Dec 2020	644
ANDERSON RAYMOND WILLIAM Director		Direct		31 Dec 2020	644
KLAUSNER ARTHUR J Director		Direct		31 Dec 2020	644
BROWN MICHAEL J Director		Direct		31 Dec 2020	644
STARR CHRISTOPHER M Director		Direct		30 June 2020	323
ANDERSON RAYMOND WILLIAM Director		Direct		30 June 2020	323
KLAUSNER ARTHUR J Director		Direct		30 June 2020	323
BROWN MICHAEL J Director		Direct		30 June 2020	323
STARR CHRISTOPHER M Director		Direct		31 Mar 2020	322
ANDERSON RAYMOND WILLIAM Director		Direct		31 Mar 2020	322
KLAUSNER ARTHUR J Director		Direct		31 Mar 2020	322
BROWN MICHAEL J Director		Direct		31 Mar 2020	322
TSUCHIMOTO-EVANS KIM R Chief Financial Officer	Purchase at price 8.00 per share.	Direct	2,600	18 Dec 2019	325
LEO KARL Beneficial Owner of more than 10% of a Class of Security	Purchase at price 8.00 per share.	Indirect	1,252,510	18 Dec 2019	156,564
HENDRICKS DIANE Beneficial Owner of more than 10% of a Class of Security	Purchase at price 8.00 per share.	Indirect	3,750,000	18 Dec 2019	468,750
TACTIC PHARMA, L.L.C. Beneficial Owner of more than 10% of a Class of Security	Purchase at price 8.00 per share.	Indirect	1,000,000	18 Dec 2019	125,000
RIOUX PATRICE P Officer	Conversion of Exercise of derivative security at price 0.00 - 6.00 per share.	Direct	109,998	26 Nov 2019	18,433

ALL ORDS8,456.80+13.10(+0.16%)

AUD/USD0.6718-0.0032(-0.48%)

ASX 2008,187.40+10.50(+0.13%)

OIL73.32-0.25(-0.34%)

GOLD2,626.30-9.10(-0.35%)

Bitcoin AUD90,873.42-1,889.91(-2.04%)

Monopar Therapeutics Inc. (MNPR)

Insider transactions

Insider transactions reported - last two years

ALL ORDS
8,456.80
+13.10(+0.16%)

AUD/USD
0.6718
-0.0032(-0.48%)

ASX 200
8,187.40
+10.50(+0.13%)

OIL
73.32
-0.25(-0.34%)

GOLD
2,626.30
-9.10(-0.35%)

Bitcoin AUD
90,873.42
-1,889.91(-2.04%)